In the late 1940s, high blood pressure was a challenging condition to treat, with few reliable options available. Cardiologist Dr Rustom Jal Vakil, working at King Edward Memorial Hospital in Bombay, turned his attention to Rauwolfia serpentina, a plant with a long history in Indian traditional medicine. Vakil's systematic study of the plant's effects on patients with essential hypertension provided evidence that the remedy could lower blood pressure. His findings, published in the British Heart Journal in 1949, helped bring Rauwolfia into the international medical conversation. The study's results showed that 85% of patients experienced a decrease in systolic blood pressure, and 81% experienced a decrease in diastolic blood pressure. Vakil's work played a significant role in connecting Indian medical experience with international research, and his contributions to the field were recognized with the Albert Lasker Award for Clinical Medical Research in 1957 and the Padma Bhushan in 1958. While Rauwolfia is no longer a first-line treatment for high blood pressure, Vakil's study remains an important milestone in the development of hypertension treatment. His work demonstrates the value of investigating traditional remedies with scientific rigor and highlights the potential for medical breakthroughs to emerge from unexpected sources. The discovery of reserpine, an alkaloid isolated from Rauwolfia, was a key outcome of Vakil's research and paved the way for the development of more effective treatments for high blood pressure. Today, the legacy of Vakil's work continues to inspire researchers and clinicians to explore the potential of traditional remedies in the pursuit of medical innovation.